Filing Details
- Accession Number:
- 0000899243-20-015063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-03 16:17:17
- Reporting Period:
- 2020-06-01
- Accepted Time:
- 2020-06-03 16:17:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1680581 | Fulcrum Therapeutics Inc. | FULC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1577034 | J Robert Gould | C/O Fulcrum Therapeutics, Inc. 26 Landsdowne Street Cambridge MA 02139 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-06-01 | 5 | $20.00 | 549,031 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-06-02 | 2,797 | $20.00 | 546,234 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019.
Billionaire Hedge Funds
